CBUS - NASDAQ

Cibus, Inc.

CBUS·NASDAQ

$1.40

-1.1%

HealthcareBiotechnology

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$63.68M

EPS-2.7800

P/E Ratio-0.50

Earnings Date08/06/2026

305.05M

Assets

-13%

3Y+1261.0%

5Y+382.0%

10Y+1735.0%

283.22M

Total Liabilities

12%

3Y+1765.0%

5Y+971.0%

10Y+7983.0%

21.83M

Total Equity

-78%

3Y+202.0%

5Y-41.0%

10Y+66.0%

Cibus, Inc. Funding & Solvency Profile

CBUS · NASDAQ

Current Assets

Cash & Cash Equivalents9.92M

Net Receivables703.00K

Inventory0.00

Other Current Assets1.44M

Total Current Assets12 M

Non-Current Assets

Property, Plant & Equipment27.86M

Goodwill & Intangible Assets264.19M

Long-Term Investments0.00

Other Non-Current Assets926.00K

Total Non-Current Assets29 M

Total Assets

305.05M

Financial Health Analysis

Current Ratio

0.72x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

12.97x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-4789000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

4% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

Cibus, Inc. Balance Sheet

CBUS • NASDAQ

Cibus, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	9.9M	14.4M	32.7M	3.4M	13.8M	17.3M	58.6M	93.8M	56.7M	5M	24.7M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	11.7M	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	9.9M	14.4M	32.7M	3.4M	13.8M	29M	58.6M	93.8M	56.7M	5M	24.7M
Net Receivables	703K	1M	530K	0.0	0.0	4.9M	1.1M	46K	167K	157K	334K
Accounts Receivables	703K	1M	530K	0.0	0.0	4.9M	1.1M	0.0	0.0	110K	217K
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46K	167K	47K	0.0
Inventory	0.0	0.0	0.0	0.0	0.0	1.4M	2.6M	1.3M	0.0	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	859K	3.9M	808K	933K	347K	282K	11K
Other Current Assets	1.4M	1.5M	2M	705K	499K	393K	388K	67K	138K	0.0	0.0
Total Current Assets	12.1M	16.9M	35.2M	4.1M	15.2M	39.6M	63.5M	95.5M	57.5M	5.5M	25M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	27.9M	44.7M	37.5M	18.1M	21.7M	22.9M	23.2M	21.9M	14.4M	11M	915K
Goodwill	232.5M	253.5M	434.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	31.7M	33.6M	35.4M	158K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	264.2M	287M	470.3M	158K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	1M	1.1M	0.0	0.0	0.0
Other Non-Current Assets	926K	1.4M	1.4M	0.0	282K	877K	324K	306K	357K	164K	48K
Total Non-Current Assets	293M	333.1M	509.2M	18.3M	22M	23.7M	24.6M	23.3M	14.7M	11.2M	963K
Total Assets	305M	350.1M	544.4M	22.4M	37.2M	63.3M	88.1M	118.8M	72.2M	16.6M	26M
LIABILITIES
CURRENT LIABILITIES
Total Payables	8.1M	6M	6.1M	515K	1.4M	1.7M	1.1M	2.7M	2.4M	357K	384K
Accounts Payable	8.1M	6M	6.1M	340K	1.3M	929K	1.1M	818K	1M	357K	304K
Other Payables	0.0	0.0	0.0	175K	172K	766K	0.0	1.9M	1.4M	0.0	80K
Accrued Expenses	0.0	2.3M	1.7M	173K	339K	2.9M	2.2M	2M	449K	332K	470K
Short Term Debt	3.2M	436K	833K	0.0	0.0	0.0	0.0	0.0	1.4M	0.0	0.0
Capital Lease Obligations (Current)	0.0	4.4M	6.1M	464K	370K	364K	356K	258K	0.0	0.0	0.0
Deferred Revenue	536K	932K	1.2M	107K	0.0	0.0	5.7M	248K	43K	101K	182K
Other Current Liabilities	5.1M	5.9M	5.3M	403K	2.7M	2M	3.6M	1.8M	78K	2.1M	0.0
Total Current Liabilities	16.9M	19.9M	21.3M	1.7M	4.9M	6.9M	7.2M	7M	4.3M	2.9M	1M
NON-CURRENT LIABILITIES
Long Term Debt	235M	226K	536K	0.0	0.0	1.5M	0.0	0.0	0.0	0.0	0.0
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	289K	639K	702K
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-10.1M	0.0	0.0
Other Non-Current Liabilities	1.6M	200.9M	167.1M	79K	702K	113K	150K	163K	0.0	0.0	0.0
Total Non-Current Liabilities	266.4M	232.4M	184.8M	13.5M	18.2M	19.5M	18.4M	18.4M	10.4M	639K	702K
Capital Lease Obligations	29.8M	35.6M	23.3M	13.9M	17.9M	18.2M	18.6M	18.5M	10.1M	0.0	0.0
Total Liabilities	283.2M	252.2M	206.1M	15.2M	23.1M	26.5M	25.6M	25.4M	14.7M	3.5M	1.7M
SHAREHOLDERS' EQUITY
Treasury Stock	-2.1M	-2M	-1.8M	-1M	-1M	-1M	-1M	-230K	0.0	0.0	0.0
Common Stock	79K	9K	8K	5K	4K	4K	3K	3K	3K	1K	1K
Additional Paid-In Capital	882.2M	825.3M	775M	220.4M	211.3M	204.8M	185.6M	176.1M	112M	41.7M	40.7M
Retained Earnings	-858.3M	-731.2M	-479.8M	-212.2M	-196.1M	-166.9M	-122.1M	-82.4M	-54.5M	-28.6M	-16.5M
Accumulated Other Comprehensive Income/Loss	39K	15K	8K	0.0	0.0	0.0	17K	-2.1M	-1.3M	-732K	-387K
Total Stockholders' Equity	21.8M	92.2M	293.5M	7.2M	14.1M	36.9M	62.5M	93.4M	57.5M	13.1M	24.3M
Total Equity	21.8M	97.8M	338.3M	7.2M	14.1M	36.9M	62.5M	93.4M	57.5M	13.1M	24.3M
Minority Interest	0.0	5.7M	44.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	305M	350.1M	544.4M	22.4M	37.2M	63.3M	88.1M	118.8M	72.2M	16.6M	26M
Total Investments	0.0	0.0	0.0	0.0	0.0	11.7M	1M	1.1M	0.0	0.0	0.0
Total Debt	268M	36.3M	24.6M	13.9M	17.9M	19.8M	18.6M	18.5M	10.1M	0.0	0.0
Net Debt	258M	21.9M	-8.1M	10.5M	4.1M	2.5M	-40M	-75.3M	-46.5M	-5M	-24.7M
Shares Outstanding	52,540,345	52,540,345	52,540,345	52,540,345	52,540,345	52,540,345	52,540,345	52,540,345	52,540,345	52,540,345	52,540,345

SEC Filings

CBUS - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
S-3 S-3 N/A	May 15, 2026	May 15, 2026		View Filing
10-Q 10-Q 2026 Q1 Q1	May 14, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 14, 2026	May 14, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 20, 2026	June 02, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 10, 2026	April 07, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 27, 2026	March 25, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 17, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 17, 2026	March 17, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 30, 2026	January 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 28, 2026	January 28, 2026	2026	View Filing

Showing 1 to 10 of 203 filings

Related Guides

Blog Categories

Continue your CBUS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.